Cargando…
SMAD4 Loss triggers the phenotypic changes of pancreatic ductal adenocarcinoma cells
BACKGROUND: SMAD4 is a gastrointestinal malignancy-specific tumor suppressor gene found mutated in one third of colorectal cancer specimens and half of pancreatic tumors. SMAD4 inactivation by allelic deletion or intragenic mutation mainly occurs in the late stage of human pancreatic ductal adenocar...
Autores principales: | Chen, Yu-Wen, Hsiao, Pi-Jung, Weng, Ching-Chieh, Kuo, Kung-Kai, Kuo, Tzu-Lei, Wu, Deng-Chyang, Hung, Wen-Chun, Cheng, Kuang-Hung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4007528/ https://www.ncbi.nlm.nih.gov/pubmed/24625091 http://dx.doi.org/10.1186/1471-2407-14-181 |
Ejemplares similares
-
Quantitative Proteomic Analysis of Differentially Expressed Protein Profiles Involved in Pancreatic Ductal Adenocarcinoma
por: Kuo, Kung-Kai, et al.
Publicado: (2016) -
SMAD4 and the TGFβ Pathway in Patients with Pancreatic Ductal Adenocarcinoma
por: Dardare, Julie, et al.
Publicado: (2020) -
Clinicopathological significance of SMAD4 loss in pancreatic ductal adenocarcinomas: a systematic review and meta-analysis
por: Wang, Jin-Dao, et al.
Publicado: (2016) -
Betulinic Acid Affects the Energy-Related Proteomic Profiling in Pancreatic Ductal Adenocarcinoma Cells
por: Chiu, Ching-Feng, et al.
Publicado: (2021) -
Deciphering The Potential Role of Hox Genes in Pancreatic Cancer
por: Kuo, Tzu-Lei, et al.
Publicado: (2019)